v3.24.2
Segment financial information - reportable segments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Information by reportable segment        
Net sales $ 1,702.8 $ 1,743.9 $ 3,382.6 $ 3,524.2
Adjusted Operating Income 277.2 318.9 535.6 642.0
Corporate        
Information by reportable segment        
Adjusted Operating Income (17.7) (15.0) (34.4) (31.6)
Laboratory Solutions        
Information by reportable segment        
Net sales 1,155.7 1,193.8 2,312.8 2,396.8
Laboratory Solutions | Operating Segments        
Information by reportable segment        
Adjusted Operating Income 150.9 179.7 299.1 351.9
Bioscience Production        
Information by reportable segment        
Net sales 547.1 550.1 1,069.8 1,127.4
Bioscience Production | Operating Segments        
Information by reportable segment        
Adjusted Operating Income $ 144.0 $ 154.2 $ 270.9 $ 321.7